A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: suggest (285), remind (88)

InPEtoposideIfosfamide(5dy)Ver1

Description
Chemotherapy Protocol SARCOMA ETOPOSIDE-IFOSFAMIDE (5 day) Inpatient Regimen Regimen Sarcoma-InP-Etoposide-Ifosfamide (5 day) Indication Second line treatment of
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InPEtoposideIfosfamide5dyVer1.pdf

InP Ifosfamide(2day)Ver1

Description
Chemotherapy Protocol SARCOMA IFOSFAMIDE (2 day) Inpatient Regimen Regimen Sarcoma-InP-Ifosfamide (2 day) Indication Advanced or metastatic soft tissue sarcoma
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InPIfosfamide2dayVer1.pdf

InP DoxorubicinIfosfamideVer1

Description
Chemotherapy Protocol SARCOMA DOXORUBICIN-IFOSFAMIDE In-Patient Regimen Regimen Sarcoma – InP-Doxorubicin - Ifosfamide Indication Soft tissue sarcoma WHO performance status 0
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InPDoxorubicinIfosfamideVer1.pdf

InP Doxorubicin Etoposide Ifosfamide Vincristine VIDEVer1

Description
Chemotherapy Protocol SARCOMA DOXORUBICIN-ETOPOSIDE-IFOSFAMIDE -VINCRISTINE (VIDE) Inpatient Regimen Regimen Sarcoma-InP- Doxorubicin-Etoposide-Ifosfamide-Vincristine (VIDE) Indication Ewings Sarcoma
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InPDoxorubicinEtoposideIfosfamideVincristineVIDEVer1.pdf

InP-Cisplatin(75)-Docetaxel(75)-Fluorouracil(4000)

Description
Chemotherapy Protocol HEAD AND NECK CANCER CISPLATIN (75)-DOCETAXEL(75)-FLUOROURACIL(4000) In-Patient Regimen Regimen • Head and Neck Cancer – InP
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/InP-Cisplatin75-Docetaxel75-Fluorouracil4000.pdf

InP-Cisplatin(80)-Docetaxel(40)-Fluorouracil(2800)

Description
Chemotherapy Protocol HEAD AND NECK CANCER CISPLATIN (80)-DOCETAXEL(40)-FLUOROURACIL(2800) In-Patient Regimen Regimen • Head and Neck Cancer – InP
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/InP-Cisplatin80-Docetaxel40-Fluorouracil2800.pdf

Cisplatin (75)-Docetaxel(75)-Fluorouracil(4000)

Description
Chemotherapy Protocol HEAD AND NECK CANCER CISPLATIN (75)-DOCETAXEL(75)-FLUOROURACIL(4000) Regimen • Head and Neck Cancer – Cisplatin(75)-Docetaxel(75
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/Cisplatin-75-Docetaxel75-Fluorouracil4000.pdf

NilotinibChronic

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Nilotinib (chronic phase) Regimen • CML – Nilotinib (chronic phase) Indication • As an option for the treatment of
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/NilotinibChronic.pdf

NilotinibAccelerated

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Nilotinib (accelerated phase) Regimen • CML – Nilotinib (accelerated phase) Indication • Nilotinib is an option for the treatment
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/NilotinibAccelerated.pdf

Docetaxel (75) Ver 1.1

Description
Chemotherapy Protocol BREAST CANCER DOCETAXEL (75) Regimen Breast Cancer – Docetaxel (75) Indication Treatment of locally advanced or metastatic HER2 positive breast
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Docetaxel-75-Ver-11.pdf
51 to 60 of 117
Previous … 4 5 6 7 8 … Next